Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Alzheimer's Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02246075
What this trial is testing

Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine

Who this might be right for
Alzheimer's DiseaseDementiaCognition
FORUM Pharmaceuticals Inc
Testing effectiveness (Phase 2)Looking for participantsNCT06189963
What this trial is testing

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

Who this might be right for
Moderate Alzheimer Disease
NKGen Biotech, Inc. 36
Not applicableUnknownNCT04203121
What this trial is testing

The Safety and Scientific Validity of Low-dose Whole Brain Radiotherapy in Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
Kyung Hee University Hospital at Gangdong 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07191028
What this trial is testing

Alzheimer's Disease THErapy With NEuroaid II

Who this might be right for
Alzheimer's Disease Dementia
Moleac Pte Ltd. 350
Testing effectiveness (Phase 2)Study completedNCT00515333
What this trial is testing

TRx0014 in Patients With Mild or Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
TauRx Therapeutics Ltd 323
Large-scale testing (Phase 3)Ended earlyNCT00857233
What this trial is testing

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 297
Testing effectiveness (Phase 2)Study completedNCT00955409
What this trial is testing

Long Term Extension Study Evaluating Safety, Tolerability and Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Not applicableStudy completedNCT01380288
What this trial is testing

Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine

Who this might be right for
Alzheimer's Disease
Dong-A University 300
Post-approval studies (Phase 4)UnknownNCT01849042
What this trial is testing

Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Konkuk University Medical Center 188
Testing effectiveness (Phase 2)Study completedNCT00257673
What this trial is testing

Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Memory Pharmaceuticals 183
Early research (Phase 1)Study completedNCT00633841
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Early research (Phase 1)UnknownNCT04500847
What this trial is testing

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

Who this might be right for
Alzheimer Disease, Early OnsetMild Cognitive ImpairmentModerate Dementia
Butler Hospital 35
Testing effectiveness (Phase 2)Study completedNCT01284387
What this trial is testing

Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 126
Testing effectiveness (Phase 2)Study completedNCT00880412
What this trial is testing

Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Exonhit 197
Testing effectiveness (Phase 2)Study completedNCT03520998
What this trial is testing

Study to Assess the Safety of GRF6019 Infusions in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild to Moderate Alzheimer Disease
Alkahest, Inc. 47
Large-scale testing (Phase 3)Study completedNCT00566501
What this trial is testing

Open-Label Extension Study of 23 mg Donepezil SR in Participants With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Inc. 915
Not applicableStudy completedNCT04325204
What this trial is testing

Faith-Based Toolbox for African Americans With Dementia

Who this might be right for
Alzheimer DiseaseDementia
Emory University 54
Testing effectiveness (Phase 2)Study completedNCT00948909
What this trial is testing

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 274
Post-approval studies (Phase 4)Study completedNCT00800709
What this trial is testing

Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Mental Health Center 26
Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation